Moneycontrol PRO
HomeNewsBusinessMarketsSai Life Sciences Allots 150,500 Equity Shares Under ESOP

Sai Life Sciences Allots 150,500 Equity Shares Under ESOP

Sai Life Sciences Allots 150,500 Equity Shares Under ESOP

September 19, 2025 / 13:59 IST
Disclaimer This is an AI-assisted live blog with updates sourced from multiple news outlets and agencies Disclaimer
     
     
    26 Aug, 2025 12:21
    Volume
    Todays L/H
    More

    Sai Life Sciences Limited has revised its intimation regarding the allotment of equity shares under its Employee Stock Option Plans (ESOP). The company had inadvertently carried out the initial allotment and has requested that it be disregarded. The revised details pertain to the allotment of equity shares under the Management Employees Stock Option Plan 2018 (MESOP 2018) and ESOP Plan 2008.

    The Board of Directors, in a meeting held on September 3, 2025, approved and allotted 150,000 fully paid-up equity shares of Re.1 each under MESOP 2018, and 500 fully paid-up equity shares of Re.1 each under ESOP 2008.

    The details of the allotment are provided in Annexure-A (MESOP 2018) and Annexure-C (ESOP 2008), as per Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021. Further details as per SEBI Circular SEBI/HO/CFD/PoD2/CIR/P/0155 dated November 11, 2024, are enclosed as Annexure-B (MESOP 2018) and Annexure-D (ESOP 2008).

    Details of Allotment under MESOP 2018 (Annexure-A):

     

    • Company Name: Sai Life Sciences Limited
    • Stock Exchanges: BSE Limited and National Stock Exchange of India Limited
    • Filing Date: January 8, 2025
    • Filing Numbers: BSE (220874), NSE (46557)
    • Scheme Title: Management ESOP Plan 2018
    • Security Type: Equity Shares
    • Par Value: Re 1 per share
    • Issue Date: September 3, 2025
    • Number of Shares Issued: 150,000
    • Distinctive Numbers: 209249293 to 209399292 (inclusive)
    • ISIN: INE570L01029
    • Exercise Price: Rs 23.30 per share
    • Premium: Re 22.30 per share
    • Total Issued Shares After Issue: 209399292

     

    Details of Allotment under ESOP 2008 (Annexure-C):

     

    • Company Name: Sai Life Sciences Limited
    • Stock Exchanges: BSE Limited and National Stock Exchange of India Limited
    • Filing Date: January 8, 2025
    • Filing Numbers: BSE (220872), NSE (46558)
    • Scheme Title: Employees Stock Option Plan 2008
    • Security Type: Equity Shares
    • Par Value: Re 1 per share
    • Issue Date: September 3, 2025
    • Number of Shares Issued: 500
    • Distinctive Numbers: 209399293 to 209399792 (inclusive)
    • ISIN: INE570L01029
    • Exercise Price: Rs 188.90 per share
    • Premium: Re 187.90 per share
    • Total Issued Shares After Issue: 209399792

     

    Key Highlights from Annexure-B (MESOP 2018):

     

    • The present instance is for allotment of shares upon exercise of 150,000 options under MESOP 2018.
    • Money realized by exercise of options: INR 34,95,000.

     

    Key Highlights from Annexure-D (ESOP 2008):

     

    • The present instance is for allotment of shares upon exercise of 500 options under ESOP 2008.
    • Money realized by exercise of options: INR 94,450.

     

    The objective of both MESOP 2018 and ESOP 2008 is to incentivize, attract, retain, and reward employees, contributing to the company's growth. The vesting and exercise periods are defined as per the respective plan clauses.

     

    Alpha Desk
    first published: Sep 19, 2025 01:59 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Subscribe to Tech Newsletters

    • On Saturdays

      Find the best of Al News in one place, specially curated for you every weekend.

    • Daily-Weekdays

      Stay on top of the latest tech trends and biggest startup news.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347